|
Year |
Events |
Net Sales EUR 1 000 |
|
1988
|
- Establishment of Biohit Oy
- Basic research and market surveys
- Electonic pipettor development
- Establishment of Locus genex Oy, the current diagnostics division of the Biohit Group |
|
|
1989 |
- TEKES[1] funding received for the electronic and mechanical pipettors, pipettor tips as well as microplates |
125 |
|
1990 |
- Worldwide introduction of the electronic pipettor
- Assembling of pipettors and injection moulding begins in Kajaani, Finland
- Introduction of first monoclonal antibodies |
491 |
|
1991 |
- TEKES funding for the development of mechanical pipettors
- First deliveries of electronic pipettors
- Establishment of first subsidiary in France
- Introduction of new monoclonal antibodies |
2 143 |
|
1992 |
- Launch of the mechanical pipettor
- Launch of the multichannel electronic pipettor
- Establishment of subsidiaries in Italy and the U.K.
- Ph.D. Thesis of Tapani Tiusanen: An application invention of vertical measurement; the self-correcting, multiparameter measuring instrument |
4 244 |
|
1993 |
- Launch of the multichannel mechanical pipettor
- Co-operation with Eppendorf and bioMérieux begins
|
6 419 |
|
1994 |
- Development of the renewed electronic pipettor
- Co-operation with Ortho Diagnostic Systems of Johnson & Johnson begins
- Establishment of joint venture in Japan
- Ph.D. Thesis of Osmo Suovaniemi: The vertical measurement invention, its applications and the invention of electronic liquid handling devices
|
8 425 |
|
1995 |
- Launch of several new liquid handling products
- Establishment of subsidiary in Germany
- Co-operation with Eastman Kodak Co. Clinical Diagnostic Systems, later acquired by Johnson & Johnson begins |
10 550 |
|
1996 |
- Reinforcement of international sales and marketing
- Improvement of the cost structure and quality of products
- The GastroPanel program begins
- Ph.D. Thesis of Sari Ylätupa: An application invention of vertical measurement and immunoassays; the determination of cFn from blood samples and its importance in cancer diagnostics |
12 638 |
|
1997 |
- Moving into new facilities in Helsinki
- ISO 9001 –quality system certification
- Co-operation with Becton Dickinson and 3M begins
- Receiving EUREKA[2] status on the basis of which TEKES funding received for the GastroPanel program |
14 481 |
|
1998 |
- Assembling of pipettors and injection moulding begins in Helsinki
- Locus genex Oy and Biohit Systems, Inc. become Biohit Group companies
- External evaluation of the first test kit (Pepsinogen I) of the GastroPanel program
- Ph.D. Thesis of Auli Linnala: Basic research on Biohit’s monoclonal antibodies (cFn and tenascin), which are related with cancer diagnostics |
16 881 |
|
1999 |
- Listing on the New Market –list of the Helsinki Exchanges
- Continuation of aggressive patenting policy |
20 551 |
|
2000 |
- Completion of new production premises in Kajaani
- Accreditation of the calibration laboratory for liquid handling products
- Preparation to commence the global marketing and sales of diagnostic tests and analyzing systems
- Commencement of the sales of instruments
- Reinforcement of international collaboration and customer service organization through acquisitions in the U.S. and Russia |
24 247 |
|
2001 |
- Clinical evaluations carried out in various countries for assessing the reliability of the following diagnostic tests: GastroPanel for diagnosing Helicobacter pylori -infection and atrophic gastritis, as well as for screening the risk of gastric cancer and peptic ulcer from blood samples and tests for diagnosing SLE and lactose intolerance.
- Marketing of the GastroPanel began for research use
- Development of test kit for cellular fibronectin (cFn)
- Completion of new production premises for diagnostics in Helsinki, Finland
- Service laboratory taken into use |
25 545 |
|
2002 |
- Launch of the new mLINE mechanical pipettor range
- Enlargement of the electronic eLINE pipettor product range
- Continuation of the automatization at the production premises in Kajaani |
25 354 |
|
2003 |
- Launch of the multichannel versions of the electronic eLINE-pipettor range
- Establishement of Biohit representative office in China
- Further development of the GastroPanel and the test for diagnosing lactose intolerance
- Further development of the production at the Kajaani plant
- CE/IVD approval for Biohit's diagnostic products |
26 259 |
|
2004 |
- Launch of the multi-channel mechanical mLINE pipettor range
- Launch of quick tests for diagnosis of Helicobacter pylori infection and lactose intolerance
- U.S. Food and Drug Administration (FDA) approval for the GastroPanel test kit's serum-based H. pylori test
- Prize awarded to Biohit by VWR, one of the largest global distributors of liquid handling products |
26 702 |
|
2005 |
-China´s State Food and Drug Administration (SFDA) granted Biohit a marketing authorization for the Pepsinogen I & II and Gastrin-17 tests included in the GastroPanel examination
- Biohit starts cooperation with Luminex Corporation
- The company prepares to begin product manufacture in China
- New contracts help strengthen the company's OEM business |
28 660 |
|
2006 |
- Liquid Handling business receives ISO 13485 certification
- Production starts in China
- Chinese scientists recommend GastroPanel for use in Chinese health care
- Biohit announces its new, functional consumer food products
- Launch of the Helicobacter pylori IgA/IgG ELISA test |
31 408 |
|
2007 |
- Launch of the new Proline Plus mechanical pipette range
- Launch of GastroView (3-in-1 Indigestion Test) in the UK
- Agrrement with VWR Europe concerning liquid handling sales |
32 751 |
|
2008 |
- 20th Anniversary
- Launch of ColonView fecal occult blood test
- Launch of new filter tips
- Accreditation of calibration laboratory in Biohit Germany |
|
